Paraneoplastic Syndromes, Nervous System - 25 Studies Found
Completed |
: Pregnancy Outcomes in Congenital Myasthenie Syndrome : Congenital Myasthenic Syndrome : 2011-11-16 |
No longer available |
: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP : Lambert Eaton Myasthenic Syndrome (LEMS) : 2011-06-20 : Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Completed |
: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) : Lambert Eaton Myasthenic Syndrome : 2011-06-17 :
|
No longer available |
: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome : Lambert-Eaton Myasthenic Syndrome : 2011-06-13 : Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
Completed |
: MC-5A for Chemotherapy Induced Peripheral Neuropathy : Neuropathy, Paraneoplastic : 2010-12-09 :
|
Completed |
: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes : Congenital Myasthenic Syndrome : 2010-09-15 : Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine : Lambert-Eaton Myasthenic Syndrome : 2009-10-08 : Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
Recruiting |
: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) :
: 2009-03-30 :
|
Available |
: Treatment of Lambert-Eaton Syndrome With 3,4 DAP : Lambert Eaton Myasthenic Syndrome : 2008-06-23 : Drug: 3, 4 DAP Patients with clinically-confirmed LEMS will receive 3, 4 DAP by mouth in slowly increasi |
Completed |
: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome : Lambert-Eaton Myasthenic Syndrome : 2000-02-24 : Drug: 3,4-diaminopyridine |